Excess Estrogen & Weight Gain (belly fat) - The Problem and Solution

Print By Ori Hofmekler

Certain estrogen inhibiting compounds in food help destroy stubborn fat and also defend against cancer.
How to defend yourself against estrogen and its related chemicals.

Problem: Estrogen chemicals in food and water cause fat gain and disease.

We live in an "over estrogenic world". Never before has the human body been exposed to such an overwhelming amount of estrogen chemicals in the environment, meat, dairy, produce and water supply. Most people are prone to suffer from excess estrogen sooner or later in life. Excess estrogen, also known as estrogen dominance, occurs when estrogen levels are relatively too high, compared to other sex hormones (i.e. progesterone or testostone). Excess estrogen is associated with increased estrogen activity in the body. Estrogen chemicals are not the only reason why we suffer from excess estrogen.

Get Your JumpStart Kit Today!
Rid your body of
Estrogenic Chemicals & Toxins
the Natural Way!

Aging (both genders) is also associated with increased estrogenic activity (increased conversion of testosterone to estrogen via the aromatase enzyme). The use of drugs is another contributor to estrogen dominance. Athletes may suffer from over estrogenic activity due to steroidal drugs or "estrogen kickbacks" when on and off the drugs. Women on hormonal replacement therapy may suffer from increased levels of harmful estrogen metabolites and a related increased risk for cancer.

Consequently, there is an ever-growing rate of people who fall victim to estrogen's devastating effects, some of which include weight gain (for men, typically in the belly or chest; for women typically in the hips, lower butt, upper thighs), feminization and sterility in men and estrogen disorders, including PMS and endometriosis for women as well as estrogen related cancers for both genders, including breast, ovarian and prostate.

Estrogen related weight gain (stubborn fat)

Studies demonstrated that estrogen acts in a vicious cycle-like manner, i.e. estrogen increases the size of fat tissues and the enlarged fat tissue increases estrogen production and so on and so forth. Note that excessive fat gain can lead into over estrogenic activity (due to increased conversion of testosterone to estrogen via the aromatase enzyme in fat cells). Over estrogenic activity increases the number of estrogen receptors in fat cells thus forming a highly estrogenic fat tissue known as "stubborn fat" due to its high resistance to fat burning.

Certain estrogen inhibiting compounds in food help lose weight (stubborn fat) and also defend against cancer.

Bad and good estrogen

When over expressed, estrogen may convert to extremely toxic compounds - 16 hydroxy estrones. Known as "bad estrogens", 16 hydroxy estrones have been regarded as the culprit for some of the deadliest cancers including breast, ovarian and prostate.

Note that estrogen is not a "bad hormone". Under healthy conditions, it supports the neural, skeletal and reproductive systems. Ideally, estrogen converts to highly beneficial derivatives - the 2 hydroxy estrones, which play critical roles as antioxidants and anti-cancerous compounds. Called "good estrogens", the 2 hydroxy estrones may induce cancer cell's apoptosis (cell's suicide).

However, when the body's nutritional defenses are low and estrogen is over-expressed, it unfortunately converts instead into the toxic compounds 16 hydroxyestrones, associated with adverse effects, including stubborn fat gain and formation of cancer cells.

Nutritional defense against estrogen

Researchers found that the human body has been primarily programmed to be nourished and protected from over-estrogenic activity by certain flavones or indoles in plants and bee products that inhibit estrogen and block its conversion to the highly carcinogenic derivative 16 hydroxy estrone. Instead, estrogen converts to antioxidant, anti-cancerous compounds. Overall, estrogen inhibitors can help increase the ratios of 2 hydroxy/16 hydroxy estrone (verifiable by urinalysis), which also marks improved defense against cancer and an overall reduction in estrogenic activity.

Estrogen inhibitors stack for total body defense

It was also found that estrogen inhibitors' nutrients work better when combined together in synergy to provide a total body (systemic) defense against over-estrogenic activity in three ways:

1. Reducing estrogen receptors' activity
2. Inhibiting the cytochrome p450 aromatase activity (the enzyme that converts testosterone to estrogen)
3. Inhibiting the conversion of estrogen to 16 hydroxy estrone and instead increasing its conversion to 2 hydroxy estrone

Estrogen inhibitors - flavones and indoles

Numerous studies investigated the role of flavones in regulating estrogen. It is now known that certain nutrients help inhibit estrogen, whereas others promote it. For instance, most potent estrogen inhibitors (good guys) were found to be the antiaromatase flavones 5.7 dihydroxyflavone (derived from tobacco or passiflora), apigenine (ingredient in passiflora and chamomile) and galangin (ingredient in bee propolies). Other natural estrogen inhibitors are omega 3 oils (found in flaxseed, hempseeds or nuts). Potent estrogen regulating nutrients are also found in cruciferous vegetables. Previous studies provided substantial evidence to the highly beneficial properties of Diindoly methane (DIM) - an active indole derived from broccoli, cauliflower or cabbage, which helps block the conversion of estrogen to its adverse derivative 16 hydroxy estrone, and thus helps protect against cancer.

The researchers noted that certain flavones, in particular isoflavones such as those found in soy, actually increase aromatase and estrogenic activity, as does an excess intake of omega 6 oils (found in most vegetable oils including corn, canola, safflower and soy).

In a world which is already over estrogenic, it is critically important to know the difference between the "good guys" and the "bad guys". Any nutritional program today must balance estrogen promoting nutrients with estrogen inhibiting nutrients. Unfortunately, mainstream nutrition and the medical authorities fail to provide any guidelines of how to deal with the aforementioned.

What to do

Follow The Anti-Estrogenic Diet. Until then, increase intake of cruciferous vegetables (broccoli, cauliflower, brussel sprouts or cabbage). Eat them cooked or steamed. Cooking softens the fiber, and therefore helps release the active estrogen-inhibiting ingredients. Broccoli sprouts are rich in active indoles and should be consumed raw.

• Increase the intake of omega 3 oils derived from flaxseeds, hempseeds, or fatty fish (wild catch) such as salmon, halibut, mackerel, or black cod.
• Decrease the intake of omega 6 oils derived from soy, canola, or safflower. For that matter, stay away from margarine products, even if they claim to be cholesterol-free.
• Note that all monounsaturated oils-(omega 9) such as olive oil or nuts are neutral to estrogen activity, and therefore quite safe.
• Eat organic food. Minimize the consumption of meat or dairy, unless they are hormone and chemical free. Fruits with a peel (banana, orange or kiwi) are generally safer than fruits without a peel (berries, cherries and grapes) due to lower exposure to pesticides after peeling.
• Minimize alcohol intake. Alcohol increases estrogenic activity and its conversion to toxic derivatives.
• Supplement with estrogen inhibitors (aromatase inhibitors flavones and estrogen modulating indoles). Unfortunately, most estrogen inhibitors are derived from herbs or bee products, which are not part of our typical diet and are not always accessible in their most potent form.

The most potent viable estrogen inhibitors are:

• 5.7 dihydroxyflavone (chrysin) derived from tobacco or passiflora
• apigenine - derived from passiflora, also an ingredient in chamomile
• galangin - an ingredient of bee propolies
• diindoly methane (DIM) - derived from broccoli

Note that each of the above estrogen inhibitors requires different doses to be safely effective.

Defense Nutrition - EstroX

Defense Nutrition EstroX incorporates a blend of the three most potent estrogen inhibitors (i.e. 5.7 dihydroxyflavone, apigenine and diindoly methane). Each provides specific benefits with specific tissue affinity. Recent studies support the fact that the above stack of estrogen inhibitors is more potent than each of the individual components alone, thus facilitating a superior systemic (total body) estrogen inhibiting impact.

References

Adlercreutz, H. (2002). Phyto-oestrogens and cancer. Lancet Oncol. 3, 364-373.

Agarwal, V.R., Bulum, S.E., Leitch, M., Robrich, R., and Simpson, E.R. (1996). (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab. 81, 3843-3849.

Bravo, L. (1998). Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56, 317-333.

Bulun, S.E., Sebastian, S., Takayama, K., Suzuki, T., Sasano, H., and Shozu, M. (2003). The human CYP19 (uromatase P450) gene: update on physiologic roles and genomic organization of promoters. J. Sterold Biochem. Mol. Biol. 86, 219-224.

Campbell, D.R., and Kurzer, M.S. (1993). Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J. Steroid Biochem Mol. Biol. 46, 381-388.

Carreau, S., Lambard, S., Delalande, C., Denis-Galeraud, I., Bilinska, B., and Bourguiba, S. (2003). Aromatase expression and role of estrogens in male gonad: a review. Reprod. Biol. Endrocrinol. 1, 35.

Erlund, I., Silaste, M.L., Alfthan, G., Rantala, M., Kesaniemi, Y.A., and Aro, A. (2002). Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eru. J. Clin. Nutr. 56, 891-898.

Harada, N., Utsumi, T., and Takagi, Y. (1993). Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis, Proc. Natl. Acad. Sci. U. S. A. 90, 11312-11316.

Ibrahim, A.R., and Abul-Haij, Y.J. (1990). Aromatase inhibition by flavonoids. J. Steroid Biochem. Mol. Biol. 37, 257-260.

Karnat, A., Hinshelwood, M.M., Murry, B.A., and Mendelson, C.R. (2002). Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol. Metab. 13, 122-128.

Kao, Y.C., Zhou, C., Sherman, M., Laughton, C.A., and Chen, S. (1998). Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ. Health Perspect. 106, 85-92.

Kellis, J.T., Jr., and Vickery, L.E. (1984). Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225, 1032-1034.

Kuntz, S., Wenzel, U., and Daniel, H. (1999).Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 38, 133-142.

Kuppusamy, U.R., and Das, N.P. (1992). Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem. Pharmacol. 44, 1307-1315.

Le Bail, J.C., Champavier, Yl, Chulia, A.J., and Habrioux, G. (2000). Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci. 66, 1281-1291.

Manach, C., Scalbert., A., Morand, C., Remesy, C., and Jimenez, L. (2004). Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727-747.

Ohno, S., Shinoda, S., Toyoshima, S., Nakazawn, H., Makino, T., and Nakajin, S. (2002). Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells. J. Steroid Biochem. Mol. Biol. 80, 355-363.

Saarinen, N., Joshi, S.C., Ahotupa, M., Li, X., Ammala, J., Makela, S., and Santti, R. (2001). No evidence for the in vivo activity of aromatase-inhibiting flavonoids. J. Steroid Biochem. Mol. Biol. 78, 231-239.

Sanderson, J.T., Boerma, J., Lansbergen, G.W., and van den Berg, M. (2002). Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol. Appl. Pharmacol. 182, 44-54.

Wantanabe, M., and Nakajin, S. (2004). Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R. J. Endocrinol. 180, 125-133.

Zand, R.S., Jenkins, D.J., and Diamandis, E.P. (2000). Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res. Treat. 62, 35-49.

Zhang, J.G., Tirmenstein, M.A., Nicholls-Grzemski, F.A., and Fariss, M.W. (2001). Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent and -independent cell death: protective role of antioxidants. Arch. Biochem. Biophys. 393, 87-96.

Zhai, S., Dai, R., Friedman, F.K., and Vestal, R.E. Comparative Inhibition of Human Cytochromes P450 1A1 and 1A2 by Flavonoids

Ori Hofmekler is the author of The Anti-Estrogenic Diet, The Warrior Diet and Maximum Muscle, Minimum Fat, published by Dragon Door Publications. For more information call 1-(818)992-1994 or 1-(866)927-DIET.

Defend your body against the harmful effects of excess estrogens with The Anti-Estrogenic Diet.

Related Articles

Press Releases

www.DefenseNutrition.com Copyright © 2007 Defense Nutrition, all rights reserved.